Aspen Park Pharmaceuticals Overview

  • Year Founded
  • 2014

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 2

Employees

  • Latest Deal Type
  • M&A

Aspen Park Pharmaceuticals General Information

Description

Developer of novel therapies for premature ejaculation in men. The company focuses on the development and commercialization of novel therapies for men's health diseases and conditions, including male secondary hypogonadism, prostate cancer, and sexual dysfunction.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 944 Park Avenue
  • New York, NY 10028
  • United States
+1 (914)
Primary Industry
Therapeutic Devices
Other Industries
Pharmaceuticals
Acquirer
Vertical(s)
Corporate Office
  • 944 Park Avenue
  • New York, NY 10028
  • United States
+1 (914)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Aspen Park Pharmaceuticals Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Merger/Acquisition 31-Oct-2016 Completed Generating Revenue
2. Seed Round 31-Mar-2016 Completed Startup
1. Early Stage VC (Series A) 10-Dec-2014 Completed Startup
To view Aspen Park Pharmaceuticals’s complete valuation and funding history, request access »

Aspen Park Pharmaceuticals Patents

Aspen Park Pharmaceuticals Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2017260505-A1 Delayed release oral tamsulosin hydrochloride Inactive 04-May-2016
CA-3023106-A1 Delayed release oral tamsulosin hydrochloride Inactive 04-May-2016
EP-3452016-A1 Delayed release oral tamsulosin hydrochloride Inactive 04-May-2016
US-20190133977-A1 Delayed release oral tamsulosin hydrochloride Inactive 04-May-2016
WO-2017192808-A1 Delayed release oral tamsulosin hydrochloride Inactive 04-May-2016 A61K31/18
To view Aspen Park Pharmaceuticals’s complete patent history, request access »

Aspen Park Pharmaceuticals Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Aspen Park Pharmaceuticals FAQs

  • When was Aspen Park Pharmaceuticals founded?

    Aspen Park Pharmaceuticals was founded in 2014.

  • Where is Aspen Park Pharmaceuticals headquartered?

    Aspen Park Pharmaceuticals is headquartered in New York, NY.

  • What is the size of Aspen Park Pharmaceuticals?

    Aspen Park Pharmaceuticals has 2 total employees.

  • What industry is Aspen Park Pharmaceuticals in?

    Aspen Park Pharmaceuticals’s primary industry is Therapeutic Devices.

  • Is Aspen Park Pharmaceuticals a private or public company?

    Aspen Park Pharmaceuticals is a Private company.

  • What is Aspen Park Pharmaceuticals’s current revenue?

    The current revenue for Aspen Park Pharmaceuticals is .

  • How much funding has Aspen Park Pharmaceuticals raised over time?

    Aspen Park Pharmaceuticals has raised $1.25M.

  • When was Aspen Park Pharmaceuticals acquired?

    Aspen Park Pharmaceuticals was acquired on 31-Oct-2016.

  • Who acquired Aspen Park Pharmaceuticals?

    Aspen Park Pharmaceuticals was acquired by Veru.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process